Cargando…
SARS-CoV-2 Vaccination as a Trigger for Perinuclear Antineutrophil Cytoplasmic Antibodies (p-ANCA) Associated With Rapidly Progressive Glomerulonephritis
The coronavirus disease 2019 (COVID-19) pandemic was devastating worldwide. The introduction of severe acute respiratory syndrome coronavirus 2 vaccination has reduced transmission, hospitalizations, and deaths, with infrequent major side effects. We present the case of a 51-year-old woman with rapi...
Autores principales: | Cano-Gámez, Tábata, Teco-Cortes, Javier Alejandro, Soto-Abraham, María Virgilia, Álvarez-Hernández, Everardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633321/ https://www.ncbi.nlm.nih.gov/pubmed/36348922 http://dx.doi.org/10.7759/cureus.29924 |
Ejemplares similares
-
Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis as a Possible Side Effect of COVID-19 Vaccination
por: Noel, Edva, et al.
Publicado: (2022) -
Perinuclear Antineutrophil Cytoplasmic Antibody Positive Glomerulonephritis in a Case of Limited Cutaneous Scleroderma
por: Vora, H., et al.
Publicado: (2018) -
Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine
por: Dube, Geoffrey K., et al.
Publicado: (2021) -
Antineutrophil Cytoplasmic Antibody and Multiple Sclerosis
por: George, Jason C., et al.
Publicado: (2017) -
Tofacitinib-Induced Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis With Crescentic Glomerulonephritis
por: Asemota, Uyioghosa, et al.
Publicado: (2021)